A new orbit
There are big constraints on divergence, but opportunities too
I
N JANUARY 2017 the Conservative Party’s civil war over how to leave the European Union was just beginning. Many Tory
MPs had only a fuzzy idea of what quitting the single market and customs union would mean; some entertained themselves with a campaign to relaunch the Royal Yacht. Sir Michael Rawlins, then the head of the Medicines and Healthcare products Regulatory Agency, (
MHRA) Britain’s drugs regulator, saw the road ahead clearly.
Listen to this story
Enjoy more audio and podcasts oniOSorAndroid.
Leaving the
EU’s pharmaceutical regime, Sir Michael told a House of Lords committee, could mean that Britain was at the “back of the queue” for new treatments as drugmakers neglected Britain’s small market. The European Medicines Agency (
The European Court of Justice (CJEU) has delivered a damning verdict on the UK’s performance with regards to its pollution levels. Click to read more.
Freizeit - Coronakonformes Hobby: Die Fischerei im Kanton Uri boomt luzernerzeitung.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from luzernerzeitung.ch Daily Mail and Mail on Sunday newspapers.
Economics Versus Biodiversity? - The Good Men Project goodmenproject.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goodmenproject.com Daily Mail and Mail on Sunday newspapers.